Skip to main content
OpenTrials

Clinical trial condition

Neoplasm Metastasis

Explore clinical trials studying Neoplasm Metastasis. Study availability and eligibility vary by location and protocol.

2,438 public trials 498 recruiting studies
Refine in advanced search Browse all conditions

Neoplasm Metastasis trial results

Recruiting

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

NCT07038343

Conditions
Biliary Tract Cancer (BTC), Biliary Tract Diseases, Biliary Tract Neoplasms, +34 more
Locations
  • Avenzo Therapeutics Recruiting Site Gilbert, Arizona, United States
  • Avenzo Therapeutics Recruiting Site Los Angeles, California, United States
  • Avenzo Therapeutics Recruiting Site Denver, Colorado, United States
  • Avenzo Therapeutics Recruiting Site New Haven, Connecticut, United States
View all 18 locations
View Trial Details
Recruiting

Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced Cancer

NCT06963723

Conditions
Advanced Cancer, Behavior, Behavioral Symptoms, +8 more
Locations
  • Dignity Health Phoenix, Arizona, United States
  • New Hampshire Oncology-Hematology, PA Concord, New Hampshire, United States
  • Solinsky Center for Cancer Care Manchester, New Hampshire, United States
  • New York City Health and Hospitals New York, United States
View Trial Details
Recruiting

A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic Change

NCT05010031

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +14 more
Locations
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All protocol activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (All protocol activities) Commack, New York, United States
View Trial Details
Recruiting

Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.

NCT06697301

Conditions
Advanced Melanoma, Neoplasm Metastasis, Neoplasms, +3 more
Locations
  • Ironwood Cancer & Research Centers Chandler, Arizona, United States
  • Genesis Cancer and Blood Institute Hot Springs, Arkansas, United States
  • Helios Clinical Research Los Angeles, California, United States
  • Providence Medical Foundation Santa Rosa, California, United States
View all 107 locations
View Trial Details

Related conditions